71 results on '"Swen, J.J."'
Search Results
2. The impact of CYP2C19 genotype on phenoconversion by concomitant medication
3. The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study
4. Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients
5. Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists
6. Genome-wide association study of methotrexate-induced liver injury in rheumatoid arthritis patients
7. Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial
8. Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
9. Substrate specificity of CYP2D6 genetic variants
10. Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: a case series
11. Precision Medicine Using Pharmacogenomic Panel-Testing Current Status and Future Perspectives
12. Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics
13. 70P Fluoropyrimidine (FP) dose individualization based on pretreatment uracil levels: Safety and pharmacokinetic (PK) analysis from the Alpe2U study
14. Cost-effectiveness of pharmacogenomics-guided prescribing to prevent gene-drug-related deaths: a decision-analytic model
15. Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity
16. Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients
17. Increased Tacrolimus Exposure in Kidney Transplant Recipients With COVID-19: Inflammation-Driven Downregulation of Metabolism as a Potential Mechanism
18. Dihydropyrimidine dehydrogenase phenotyping using pretreatment uracil: a note of caution based on a large prospective clinical study
19. Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries
20. The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications
21. Pharmacogenetic Information in Clinical Guidelines: The European Perspective
22. Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device
23. Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen
24. Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers
25. DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD*2A, c.2846A>T, c.1679T>G and c.1236G>A
26. Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated Cancer
27. Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
28. A brighter future for the implementation of pharmacogenomic testing
29. Insulin-like growth factor 1 receptor expression and polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial (BOOG 2010-01)
30. Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
31. Farmacogenetica in de eerstelijnszorg. Toepassingen en toekomstverwachtingen
32. Population Pharmacokinetics and Pharmacogenetics of Once Daily Tacrolimus Formulation in Liver Transplant Patients
33. THE ROLE OF GENETIC VARIANTS GSTA1 AND CYP39A1 AND ONTOGENESIS ON BUSULFAN CLEARANCE IN PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC SCT
34. Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization
35. Evaluating the Effect of CYP3A4 and CYP3A5 Polymorphisms on Cyclosporine, Everolimus and Tacrolimus Pharmacokinetics in Renal Transplantation Patients
36. 561P - Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers
37. 452O - DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD*2A, c.2846A>T, c.1679T>G and c.1236G>A
38. EXPLORATORY ANALYSIS OF 1,936 SNPS IN 225 ADME GENES FOR ASSOCIATION WITH BUSULFAN CLEARANCE IN ADULT HEMATOPOIETIC STEM CELL RECIPIENTS
39. Alternative methods to a TaqMan assay to detect a tri-allelic single nucleotide polymorphism rs757210 in the HNF1 beta gene
40. Pharmacogenetic dose recommendations in clinical practice
41. Translating pharmacogenetics to primary care
42. Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation (Advagraf®) in liver transplant patients
43. The effect of CYP3A4*22, CYP3A5*3 and CYP3A combined genotypes on cyclosporine, everolimus and tacrolimus pharmacokinetics in renal transplant recipients
44. Genexpressie en chemotherapie respons bij acute lymfatische leukemie
45. PHC007 genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment
46. Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment
47. Personalized medicine in rheumatoid arthritis
48. Towards solving the missing heritability in pharmacogenomics
49. Genetic variants contribute to differences in response and toxicity to drugs used in autoimmune diseases: Rheumatoid arthritis and systemic lupus erythematosus
50. Precision medicine using pharmacogenomic panel testing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.